27.1.3 - Radiographic Outcomes were Concordant with Pain and Function Response: Post-hoc Analysis from a Phase 2 Study of SM04690, a WNT Pathway Inhibitor for Knee Osteoarthritis Treatment (ID 10586)
C. Swearingen, Samumed, LLC, employee and shareholder S. Kennedy, Samumed, LLC, employee and shareholder J. Tambiah, Samumed, LLC, employee and shareholder